PTEN methylation involved in benzene-induced hematotoxicity

Experimental and Molecular Pathology

Volumn 96, Issue 3, 2014, Pages 300-306

  Yang, Jing ^a   Zuo, Xin ^a   Bai, Wenlin ^a   Niu, Piye ^a   Tian, Lin ^a   Gao, Ai ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Benzene; Epigenetic modifications; Hematotoxicity; Methylation specific PCR; PTEN

Indexed keywords

BENZENE; EPIGENETIC MODIFICATIONS; HEMATOTOXICITY; METHYLATION-SPECIFIC PCR; PTEN;

ANIMALS; AZACITIDINE; BENZENE; BODY WEIGHT; CARCINOGENS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; DRUG-INDUCED LIVER INJURY; EPIGENESIS, GENETIC; GENES, TUMOR SUPPRESSOR; HYDROXAMIC ACIDS; LEUKOCYTES; MALE; PROMOTER REGIONS, GENETIC; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 84898642247     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.03.008     Document Type: Article

References (37)

1. Baeza N., Weller M., Yonekawa Y., Kleihues P., Ohgaki H. PTEN methylation and expression in glioblastomas. Acta Neuropathol. 2003, 106(5):479-485.
2. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 1998, 72:141-196.
3. Cahill N., Bergh A.C., Kanduri M., Göransson-Kultima H., Mansouri L., Isaksson A., Ryan F., Smedby K.E., Juliusson G., Sundström C., Rosén A., Rosenquist R. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013, 27(1):150-158.
4. Cameron E.E., Bachman K.E., Myöhänen S., Herman J.G., Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 1999, 21(1):103-107.
5. Deng T., Zhang Y. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-aza-2'-deoxycytidine. Life Sci. 2009, 84(9-10):311-320.
6. Di Cristofano A., Pandolfi P.P. The multiple roles of PTEN in tumor suppression. Cell 2000, 100(4):387-390.
7. DiNardo C.D., Gharibyan V., Yang H., Wei Y., Pierce S., Kantarjian H.M., Garcia-Manero G., Rytting M. Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia. Am. J. Hematol. 2013, 88(9):784-789.
8. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol. 2003, 4(6):351-358.
9. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 2007, 8(4):286-298.
10. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358(11):1148-1159.
11. Gao S., Mobley A., Miller C., Boklan J., Chandra J. Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells. Leuk. Res. 2008, 32(5):771-780.
12. Gao A., Zuo X., Liu Q., Lu X., Guo W., Tian L. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. Toxicol. Lett. 2010, 195(2-3):114-118.
13. Golding B.T., Watson W.P. Possible mechanisms of carcinogenesis after exposure to benzene. IARC Sci. Publ. 1999, 150:75-88.
14. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349(21):2042-2054.
15. Huff J. Benzene-induced cancers: abridged history and occupational health impact. Int. J. Occup. Environ. Health 2007, 13(2):213-221.
16. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128(4):683-692.
17. Jones P.A., Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 1999, 21(2):163-167.
18. Kang Y.H., Lee H.S., Kim W.H. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest. 2002, 82(3):285-291.
19. Kondo Y., Shen L., Issa J.P. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol. 2003, 23(1):206-215.
20. Linet M.S., Yin S.N., Travis L.B., Li C.Y., Zhang Z.N., Li D.G., Rothman N., Li G.L., Chow W.H., Donaldson J., Dosemeci M., Wacholder S., Blot W.J., Hayes R.B. Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Benzene Study Group. Environ. Health Perspect. 1996, 104(Suppl. 6):1353-1364.
21. Liu Z., Zhang L., Ding F., Li J., Guo M., Li W., Wang Y., Yu Z., Zhan Q., Wu M., Liu Z. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Cancer Lett. 2005, 230(2):271-283.
22. Liu Y.L., Castleberry R.P., Emanuel P.D. PTEN deficiency is a common defect in juvenile myelomonocytic leukemia. Leuk. Res. 2009, 33(5):671-677.
23. Lubecka-Pietruszewska K., Kaufman-Szymczyk A., Stefanska B., Fabianowska-Majewska K. Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. Biochem. Biophys. Res. Commun. 2013, 430(2):623-628.
24. Marks P., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 2001, 1(3):194-202.
25. Park H.J., Kim M.J., Ha E., Chung J.H. Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine 2008, 15(1-2):147-151.
26. Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin. Cell Dev. Biol. 2004, 15(2):171-176.
27. Pei L., Choi J.H., Liu J., Lee E.J., McCarthy B., Wilson J.M., Speir E., Awan F., Tae H., Arthur G., Schnabel J.L., Taylor K.H., Wang X., Xu D., Ding H.F., Munn D.H., Caldwell C., Shi H. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics 2012, 7(6):567-578.
28. Salvesen H.B., MacDonald N., Ryan A., Jacobs I.J., Lynch E.D., Akslen L.A., Das S. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int. J. Cancer 2001, 91(1):22-26.
29. Sato K., Tamura G., Tsuchiya T., Endoh Y., Sakata K., Motoyama T., Usuba O., Kimura W., Terashima M., Nishizuka S., Zou T., Meltzer S.J. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virchows Arch. 2002, 440(2):160-165.
30. Savitz D.A., Andrews K.W. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am. J. Ind. Med. 1997, 31(3):287-295.
31. Smith M.T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 1996, 104(Suppl. 6):1219-1225.
32. Snyder R. Recent developments in the understanding of benzene toxicity and leukemogenesis. Drug Chem. Toxicol. 2000, 23(1):13-25.
33. Soria J.C., Lee H.Y., Lee J.I., Wang L., Issa J.P., Kemp B.L., Liu D.D., Kurie J.M., Mao L., Khuri F.R. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin. Cancer Res. 2002, 8(5):1178-1184.
34. Stirzaker C., Song J.Z., Davidson B., Clark S.J. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 2004, 64(11):3871-3877.
35. Yin S.N., Hayes R.B., Linet M.S., Li G.L., Dosemeci M., Travis L.B., Zhang Z.N., Li D.G., Chow W.H., Wacholder S., Blot W.J. An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ. Health Perspect. 1996, 104(Suppl. 6):1339-1341.
36. Yin L., Cai W.J., Liu C.X., Chen Y.Z., Hu J.M., Jiang J.F., Li H.A., Cui X.B., Chang X.Y., Zhang W.J., Sun K., Li F. Analysis of PTEN methylation patterns in soft tissue sarcomas by MassARRAY spectrometry. PLoS One 2013, 8(5):e62971.
37. Zhu W.G., Lakshmanan R.R., Beal M.D., Otterson G.A. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res. 2001, 61(4):1327-1333.